Back
The FDA approval of pembrolizumab for patients with TMB >10 mut/Mb: was it a wise decision? No.
Journal article

The FDA approval of pembrolizumab for patients with TMB >10 mut/Mb: was it a wise decision? No.

  • Prasad V Department of Epidemiology and Biostatistics, University of California San Francisco, USA; Department of Medicine, University of California San Francisco, USA. Electronic address: vinayak.prasad@ucsf.edu.
  • Addeo A Department of Oncology, University Hospital of Geneva, Switzerland.
  • 2020-08-11
Published in:
  • Annals of oncology : official journal of the European Society for Medical Oncology. - 2020
Adult
Antibodies, Monoclonal, Humanized
Biomarkers, Tumor
Child
Humans
Neoplasms
Power, Psychological
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/46839
Statistics
Document views: 32 File downloads: